Atlas Crest Investment Corp. II (ACII) 10-Q 9 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 07, 2022
Document Information
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Entity File Number	001-39999
Entity Registrant Name	ATLAS CREST INVESTMENT CORP. II
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-4381723
Entity Address, Address Line One	399 Park Avenue
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	883-3800
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001838614
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Transition Report	false
Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant
Document Information
Title of 12(b) Security	Units, each consisting of one share of Class A Common Stock and one-fourth of one Redeemable Warrant
Trading Symbol	ACII.U
Security Exchange Name	NYSE
Class A Common Stock
Document Information
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	ACII
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		34,500,000
Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share
Document Information
Title of 12(b) Security	Warrants, each exercisable for one share of Class A Common Stock for $11.50 per share
Trading Symbol	ACII WS
Security Exchange Name	NYSE
Class B Common Stock
Document Information
Entity Common Stock, Shares Outstanding		8,625,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash	$ 308,920	$ 125,304
Prepaid expenses and other current assets	196,939	532,085
Total current assets	505,859	657,389
Investments held in Trust Account	347,314,019	345,095,241
TOTAL ASSETS	347,819,878	345,752,630
Current liabilities:
Accounts payable	84,636	242,503
Accrued expenses	355,179	158,494
Accrued compensation	92,275
Income tax payable	408,357
Franchise tax payable	28,800	200,000
Convertible promissory note - related party	81,000
Total current liabilities	1,050,247	600,997
Warrant liabilities	582,333	11,997,166
Total Liabilities	1,632,580	12,598,163
Commitments and Contingencies
Stockholders' Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2022 and December 31, 2021
Accumulated deficit	(590,427)	(11,846,396)
Total Stockholders' Deficit	(589,564)	(11,845,533)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	347,819,878	345,752,630
Common Class A subject to possible redemption
Current liabilities:
Class A common stock, $0.0001 par value, subject to possible redemption; 34,500,000 shares at redemption value at September 30, 2022 and December 31, 2021	346,776,862	345,000,000
Class B Common Stock
Stockholders' Deficit:
Common stock	$ 863	$ 863

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Preferred stock, par value (per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized	1,000,000	1,000,000
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Class A Common Stock
Common shares, par value (per share)	$ 0.0001	$ 0.0001
Common shares, authorized	200,000,000	200,000,000
Common Class A subject to possible redemption
Shares subject to possible redemption, par value (in dollars per share)	$ 0.0001	$ 0.0001
Class A common stock subject to possible redemption, outstanding (in shares)	34,500,000	34,500,000
Common Class A not subject to possible redemption
Common shares, issued	0	0
Common shares, outstanding	0	0
Class B Common Stock
Common shares, par value (per share)	$ 0.0001	$ 0.0001
Common shares, authorized	20,000,000	20,000,000
Common shares, issued	8,625,000	8,625,000
Common shares, outstanding	8,625,000	8,625,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating and formation costs	$ 436,923	$ 288,736	$ 1,365,446	$ 729,981
Franchise tax expense	50,000	50,273	150,050	149,180
Loss from operations	(486,923)	(339,009)	(1,515,496)	(879,161)
Gain on investments held in Trust Account	1,931,986	40,875	2,603,778	70,631
Loss on sale of private placement warrants				(118,670)
Expensed offering costs				(289,922)
Gain on change in fair value of warrant liabilities	1,455,834	4,545,504	11,414,833	9,754,087
Gain on change in fair value convertible promissory note - related party	41,000	0	154,200	0
Income before income taxes	2,941,897	4,247,370	12,657,315	8,536,965
Income tax expense	(448,277)		(493,357)
Net income	$ 2,493,620	$ 4,247,370	$ 12,163,958	$ 8,536,965
Class A Common Stock
Basic net income per share	$ 0.06	$ 0.10	$ 0.28	$ 0.22
Diluted net income per share	$ 0.06	$ 0.10	$ 0.28	$ 0.22
Basic weighted average shares outstanding	34,500,000	34,500,000	34,500,000	29,571,429
Diluted weighted average shares outstanding	34,500,000	34,500,000	34,500,000	29,571,429
Class B Common Stock
Basic net income per share	$ 0.06	$ 0.10	$ 0.28	$ 0.22
Diluted net income per share	$ 0.06	$ 0.10	$ 0.28	$ 0.22
Basic weighted average shares outstanding	8,625,000	8,625,000	8,625,000	8,464,286
Diluted weighted average shares outstanding	8,625,000	8,625,000	8,625,000	8,464,286

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Class A Common Stock Common Stock	Class B Common Stock Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2020	$ 0	$ 863	$ 24,137	$ (2,267)	$ 22,733
Balance at the beginning (in shares) at Dec. 31, 2020	0	8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Class A common stock to redemption amount			(24,137)	(20,139,490)	(20,163,627)
Net income (loss)				9,060,857	9,060,857
Balance at the end at Mar. 31, 2021		$ 863		(11,080,900)	(11,080,037)
Balance at the end (in shares) at Mar. 31, 2021		8,625,000
Balance at the beginning at Dec. 31, 2020	$ 0	$ 863	24,137	(2,267)	22,733
Balance at the beginning (in shares) at Dec. 31, 2020	0	8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)					8,536,965
Balance at the end at Sep. 30, 2021		$ 863		(11,604,792)	(11,603,929)
Balance at the end (in shares) at Sep. 30, 2021		8,625,000
Balance at the beginning at Mar. 31, 2021		$ 863		(11,080,900)	(11,080,037)
Balance at the beginning (in shares) at Mar. 31, 2021		8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				(4,771,262)	(4,771,262)
Balance at the end at Jun. 30, 2021		$ 863		(15,852,162)	(15,851,299)
Balance at the end (in shares) at Jun. 30, 2021		8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				4,247,370	4,247,370
Balance at the end at Sep. 30, 2021		$ 863		(11,604,792)	(11,603,929)
Balance at the end (in shares) at Sep. 30, 2021		8,625,000
Balance at the beginning at Dec. 31, 2021	$ 0	$ 863	0	(11,846,396)	(11,845,533)
Balance at the beginning (in shares) at Dec. 31, 2021	0	8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds received in excess of initial fair value of convertible promissory note - related party			543,900		543,900
Net income (loss)				6,792,718	6,792,718
Balance at the end at Mar. 31, 2022		$ 863	543,900	(5,053,678)	(4,508,915)
Balance at the end (in shares) at Mar. 31, 2022		8,625,000
Balance at the beginning at Dec. 31, 2021	$ 0	$ 863	0	(11,846,396)	(11,845,533)
Balance at the beginning (in shares) at Dec. 31, 2021	0	8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)					12,163,958
Balance at the end at Sep. 30, 2022		$ 863		(590,427)	(589,564)
Balance at the end (in shares) at Sep. 30, 2022		8,625,000
Balance at the beginning at Mar. 31, 2022		$ 863	543,900	(5,053,678)	(4,508,915)
Balance at the beginning (in shares) at Mar. 31, 2022		8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation			41,507		41,507
Accretion of Class A common stock to redemption amount			(341,953)		(341,953)
Net income (loss)				2,877,620	2,877,620
Balance at the end at Jun. 30, 2022		$ 863	243,454	(2,176,058)	(1,931,741)
Balance at the end (in shares) at Jun. 30, 2022		8,625,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation			12,566		12,566
Accretion of Class A common stock to redemption amount			(526,920)	(907,989)	(1,434,909)
Proceeds received in excess of initial fair value of convertible promissory note - related party			$ 270,900		270,900
Net income (loss)				2,493,620	2,493,620
Balance at the end at Sep. 30, 2022		$ 863		$ (590,427)	$ (589,564)
Balance at the end (in shares) at Sep. 30, 2022		8,625,000

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income	$ 12,163,958	$ 8,536,965
Adjustments to reconcile net income to net cash used in operating activities:
Stock-based compensation expense	54,073
Expensed offering costs		289,922
Gain on change in fair value of convertible note	(154,200)	0
Gain on investments held in Trust Account	(2,603,778)	(70,631)
Loss on sale of private placement warrants		118,670
Gain on change in fair value of warrant liabilities	(11,414,833)	(9,754,087)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	335,146	(624,571)
Accounts payable	(157,867)	29,520
Accrued expenses	196,685	(2,267)
Accrued compensation	92,275
Income tax payable	408,357
Franchise tax payable	(171,200)	149,180
Net cash used in operating activities	(1,251,384)	(1,327,299)
Cash Flows from Investing Activities:
Cash deposited in Trust Account		(345,000,000)
Proceeds from Trust Account to pay franchise tax	300,000
Proceeds from Trust Account to pay income taxes	85,000
Net cash provided by (used in) investing activities	385,000	(345,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of convertible promissory note - related party	1,050,000
Repayment of promissory note to related party		(300,000)
Proceeds from initial public offering, net of underwriter's discount paid		338,100,000
Proceeds from sale of private placement warrants		8,900,000
Offering costs paid		(443,549)
Net cash provided by financing activities	1,050,000	346,256,451
Net Change in Cash	183,616	(70,848)
Cash - Beginning of Period	125,304	325,000
Cash - End of Period	308,920	254,152
Supplemental disclosure of noncash investing and financing activities:
Accretion of Class A common stock subject to possible redemption to redemption value	$ 1,776,862	20,163,627
Reclassification of deferred offering costs to equity upon completion of the initial public offering		$ 60,000

DESCRIPTION OF ORGANIZATION, BU

DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN	9 Months Ended
	Sep. 30, 2022
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN	NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN Atlas Crest Investment Corp. II (the “Company” or “Atlas”) is a blank check company incorporated in Delaware on December 21, 2020. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2022, the Company had not commenced any operations. All activity for the period from December 21, 2020 (inception) through September 30, 2022 relates to the Company’s formation, the initial public offering (“Initial Public Offering”) as described below, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income or gains on investments on the cash and investments held in a trust account from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The registration statement for the Company’s Initial Public Offering was declared effective on February 3, 2021. On February 8, 2021, the Company consummated the Initial Public Offering of 34,500,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $345,000,000, which is discussed in Note 3. Following the closing of the Initial Public Offering on February 8, 2021, an amount of $345,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants (as defined in Note 4) was placed in a trust account (the “Trust Account”), invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with maturities of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the consummation of a Business Combination or (ii) the distribution of the funds in the Trust Account to the Company’s stockholders, as described below. Transaction costs related to the issuances described above amounted to $7,343,549, consisting of $6,900,000 of underwriting fees and $443,549 of other costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. New York Stock Exchange rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the signing of a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders are entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity The Company will proceed with the Business Combination only if the Company has net tangible assets of at least $5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its amended and restated certificate of incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the Business Combination is required by law, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, Atlas Crest Investment II LLC (the “Sponsor”) has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed Business Combination or do not vote at all. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within 24 months from the closing of the Initial Public Offering and (c) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until February 8, 2023 to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay our taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. ​

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 18, 2022. The interim results for the periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future interim periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. The Company has implemented the aforementioned exemptions. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021. As of September 30, 2022 and December 31, 2021, the Company had operating cash (i.e. cash held outside the Trust Account) of $308,920 and $125,304, respectively. Investments Held in Trust Account At September 30, 2022 and December 31, 2021, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in gain on investments held in Trust Account in the accompanying statements of operations. Interest income from investments held in Trust Account is included in gain on investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. Class A Common Stock Subject to Possible Redemption All of the 34,500,000 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Amended and Restated Certificate of Incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Therefore, all Class A common stock has been classified outside of permanent equity. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid-in capital and accumulated deficit. The redemption value of the redeemable common stock as of September 30, 2022 increased as the income earned on the Trust Account exceeds the Company’s expected tax obligations plus up to $100,000 to pay dissolution expenses (see Note 1). As such, the Company recorded an increase in the carrying amount of the redeemable common stock of $1,776,862 during the nine months ended September 30, 2022. As of September 30, 2022 and December 31, 2021, the Class A common stock subject to redemption reflected in the balance sheet are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 345,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (13,110,000) Issuance costs allocated to Class A common stock ​ (7,053,627) Plus: ​ ​ Accretion of carrying value to redemption value ​ 20,163,627 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 345,000,000 Accretion of carrying value to redemption value ​ ​ 1,776,862 Class A common stock subject to possible redemption at September 30, 2022 ​ $ 346,776,862 ​ Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC Topic 340, Other Assets and Deferred Costs Expenses of Offering Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC Topic 815, Derivatives and Hedging For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The initial fair value of the Public Warrants was estimated using a Monte Carlo simulation approach and the initial and subsequent fair value of the Private Placement Warrants was estimated using a Modified Black-Scholes model. The subsequent measurement of the fair value of the Public Warrants was measured using quoted market prices (see Note 9). Convertible Promissory Note - Related Party The Company accounts for the convertible promissory notes under ASC 815. The Company has made the election under 815-15-25 to account for the notes under the fair value option. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet thereafter. Differences between the face value of the note and fair value at issuance are recognized as either an expense in the statement of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as non-cash gains or losses in the statement of operations. Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation - Stock Compensation Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. While ASC 740 identifies usage of an effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant, unusual or infrequent. Computing the effective tax rate for the Company is complicated due to the potential impact of the Company’s change in fair value of warrants (or any other change in fair value of a complex financial instrument), the timing of any potential business combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expense in a current period based on ASC 740-270-25-3 which states, “If an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (benefit) but is otherwise able to make a reasonable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate. As such, the Company is computing its taxable income and associated income tax provision based on actual results through September 30, 2022. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023 (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the Excise Tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, votes relating to certain amendments to the Company’s Amended and Restated Certificate of Incorporation or otherwise, may be subject to the Excise Tax. Whether and to what extent the Company would be subject to the Excise Tax in connection with a Business Combination, votes relating to certain amendments to the Company’s Amended and Restated Certificate of Incorporation or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. The mechanics of any required payment of the Excise Tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to effect an extension of the time in which the Company must complete a Business Combination or complete a Business Combination. Further, the application of the Excise Tax in the event of a liquidation is uncertain. See Note 10 for additional information on income taxes for the periods presented. Net Income Per Share of Common Stock Net income per common share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. Accretion associated with the redeemable shares of Class A common stock is excluded from net income per share as the redemption value approximates fair value. Therefore, the earnings per share calculation allocates income and losses shared pro rata between Class A and Class B common stock. As a result, the calculated net income per share is the same for Class A and Class B shares of common stock. The Company has not considered the effect of the Public Warrants and Private Placement Warrants to purchase an aggregate of 14,558,333 shares in the calculation of diluted net income per share, since the exercise of the warrants are contingent upon the occurrence of future events. The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Three Months Ended ​ Nine Months Ended ​ Nine Months Ended ​ ​ September 30, 2022 ​ September 30, 2021 ​ September 30, 2022 ​ September 30, 2021 ​ Class A Class B Class A Class B Class A Class B Class A ​ Class B Basic and diluted net income per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 1,994,896 ​ $ 498,724 ​ $ 3,397,896 ​ $ 849,474 ​ $ 9,731,166 ​ $ 2,432,792 ​ $ 6,637,190 ​ $ 1,899,775 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 29,571,429 ​ ​ 8,464,286 Basic and diluted net income per share ​ $ 0.06 ​ $ 0.06 ​ $ 0.10 ​ $ 0.10 ​ $ 0.28 ​ $ 0.28 ​ $ 0.22 ​ $ 0.22 ​ Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The Company applies ASC Topic 820, Fair Value Measurement (“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. The carrying amounts reflected in the balance sheet for current assets and current liabilities (with the exception of the convertible promissory note - related party) approximate fair value due to their short-term nature. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. See Note 9 for additional information on assets and liabilities measured at fair value. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	9 Months Ended
	Sep. 30, 2022
INITIAL PUBLIC OFFERING.
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING The registration statement for the Company’s Initial Public Offering was declared effective on February 3, 2021. On February 8, 2021, the Company completed its Initial Public Offering of 34,500,000 Units, at $10.00 per Unit, generating gross proceeds of $345,000,000. Each Unit consisted of one share of Class A common stock, $0.0001 par value, and one-fourth

PRIVATE PLACEMENT

PRIVATE PLACEMENT	9 Months Ended
	Sep. 30, 2022
PRIVATE PLACEMENT.
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 5,933,333 warrants (the “Private Placement Warrants”) at a price of $1.50 per warrant in a private placement to the Sponsor, generating gross proceeds of $8,900,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Company recognized a loss on the sale of the Private Placement Warrants of $118,670 for the nine months ended September 30, 2021 in the statement of operations as the initial fair value of the Private Placement Warrants was greater than the cash received on the sale of the Private Placement Warrants.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2022
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On December 23, 2020, the Sponsor paid $25,000 in consideration for 7,187,500 shares of Class B common stock (the “Founder Shares”). In February 2021, the Company effected a stock dividend of 0.2 shares for each issued and outstanding share of Class B common stock, resulting in an aggregate of 8,625,000 shares of Class B common stock issued and outstanding The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination, or (B) the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up. Stock-Based Compensation On January 15, 2021, the Sponsor transferred to each of the Company’s two directors (the “Original Directors”) a membership interest in the Sponsor (the “Interest”), which Interest relates to 25,000 Founder Shares each, or 50,000 Founder Shares in the Aggregate, for no cash consideration (collectively, the “Original Grant”). The Company determined that the Interests in the Founder Shares represent stock-based compensation to the Directors. The fair value of the Original Grant was determined to be $6.15 per share, or $307,500 in the aggregate. The Interests were granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Interests is recognized only when the performance condition is probable of occurrence. The Company determined that a Business Combination is not considered probable, and therefore, no stock-based compensation expense has been recognized for the Original Grant. On October 4, 2021, the Sponsor transferred to one of the Company’s executives (the “Executive”) an Interest in the Sponsor representing 125,000 Founder Shares and 66,667 Private Placement Warrants. The Company determined that the Interests in the Founder Shares and Private Placement Warrants represent stock-based compensation to the Executive. The fair value of the Interest was determined to be $4.34 per share and $0.91 per warrant, or $603,167 in the aggregate. The Interest was granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Interests is recognized only when the performance condition is probable of occurrence. The Company determined that a Business Combination is not considered probable, and therefore, no stock-based compensation expense has been recognized for the grant to the Executive. On December 21, 2021, one of the Original Directors resigned from the board of directors of the Company and forfeited their Interest for no consideration. As such, no stock-based compensation was recorded for this Original Director’s Interest. On December 27, 2021, a new director (the “Third Director”) was appointed to the board of directors. Upon appointment, the Third Director was granted an Interest in the Sponsor representing 25,000 Founder Shares pursuant to a ‘Securities Transfer Agreement’ (the “Transfer Agreement”). The Company determined that the Third Director’s Interest in the Founder Shares represents stock-based compensation. The fair value of the Interest was determined to be $3.93 per share, or $98,250 in the aggregate. The Interest was granted subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to the Interest is recognized only when the performance condition is probable of occurrence. The Company determined that a Business Combination is not considered probable, and, therefore, no stock-based compensation expense has been recognized. On June 2, 2022, the second Original Director resigned from the board of directors of the Company. In connection with the resignation, the second Original Director and the Sponsor entered into an ‘Agreement for the Redemption of Invested Capital Membership Interest and Retention of Granted Membership Interest’ (the “Retention Agreement”), pursuant to which the second Original Director retained his Interest in 25,000 Founder Shares, despite no longer serving on the board of directors of the Company. The Company determined that the Retention Agreement represented a modification to the Original Grant. Further, the Company determined that vesting of the Original Grant is no longer contingent upon the completion of a Business Combination and that the Interest granted to the second Original Director immediately vested on the date of the modification. As such, the Company recognized the fair value of the second Original Director’s Interest in the Founder Shares on the date of the modification, $1.17 per share or $29,250 in the aggregate, as stock-based compensation expense within operating and formation costs on the accompanying statements of operations. On June 3, 2022, the Sponsor and the Third Director amended and restated the Transfer Agreement (the “Amended and Restated Transfer Agreement”), pursuant to which the Third Director (i) forfeited a portion of her original Interest representing 20,937 Founder Shares; (ii) retained a portion of her Interest representing 4,063 Founder Shares (the “Retained Shares”), and (iii) was granted an Interest representing 81,250 Private Placement Warrants (the Interest in the Retained Shares and Private Placement Warrants collectively referred to as the “Retained Interest”). The Retained Interest vests over time for time served as a director assuming a service period end date of February 3, 2023. The fair value of the Retained Interest on the modification date was determined to be $1.18 per share and $0.21 per warrant, or $21,857 in the aggregate. For the three and nine months ended September 30, 2022, the Company recognized $4,990 and $15,024 as stock-based compensation within operating and formation costs on the accompanying statements of operations. On June 3, 2022, a new director (the “Fourth Director”) was appointed to the board of directors. Upon appointment, the Fourth Director entered into a securities transfer agreement with the Sponsor, pursuant to which the Fourth Director was granted an Interest in the Sponsor representing 3,750 Founder Shares and 75,000 Private Placement Warrants. The Fourth Director’s Interest vests over time for time served as a director assuming a service period end date of February 3, 2023. The fair value of the Interest granted to the Fourth Director was determined to be $1.18 per share and $0.21 per warrant, or $20,175 in the aggregate. For the three and nine months ended September 30, 2022, the Company recognized $7,576 and $9,799 as stock-based compensation within operating and formation costs on the accompanying statements of operations. Cash Compensation In addition to the Interests in the Sponsor, the Third Director and Fourth Director were granted cash compensation of $81,250 and $75,000 (or a pro rata amount based on time served and a service period end date of February 3, 2023 in the event the director terminates from the Company prior to an initial Business Combination), respectively, to be paid upon consummation of a Business Combination or the Company’s liquidation. In the event of the Company’s liquidation, the Sponsor will pay such amounts. For the three and nine months ended September 30, 2022, the Company recorded $46,712 and $92,275 in compensation expense within operating and formation costs on the accompanying statements of operations. As of September 30, 2022, $92,275 is recorded within accrued compensation on the accompanying balance sheets. Promissory Note - Related Party On December 29, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company received proceeds of $300,000 to cover expenses related to the Initial Public Offering. The Promissory Note was non-interest bearing and was payable on the earlier of September 30, 2021 or the completion of the Initial Public Offering. The outstanding balance under the Promissory Note of $300,000 was repaid at the closing of the Initial Public Offering on February 8, 2021. Due from Sponsor As of December 31, 2021, the Company was due $20,000 from the Sponsor for an over advancement of reimbursable expenses which has been repaid on February 7, 2022. The due from Sponsor balance as of December 31, 2021 is included in prepaid expenses and other current assets in the accompanying balance sheet. Administrative Support Agreement The Company entered into an agreement, commencing on the effective date of the Initial Public Offering, to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative support. Upon completion of the Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $30,000 and $30,000 of administrative support expenses for the three months ended September 30, 2022 and 2021, respectively, and incurred $60,000 and $80,000 of administrative support expenses for the nine months ended September 30, 2022 and 2021, respectively. See Note 6, under Business Combination Marketing Agreement and Related Party Loans, for additional related party transactions.

COMMITMENTS

COMMITMENTS	9 Months Ended
	Sep. 30, 2022
COMMITMENTS
COMMITMENTS	NOTE 6. COMMITMENTS Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (as defined below) (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed prior to the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Business Combination Marketing Agreement The Company engaged the representative of the underwriters and Moelis & Company LLC, an affiliate of the Sponsor, in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay the representative of the underwriters and Moelis & Company LLC a cash fee for such services upon the consummation of the Business Combination of 2.25% ($7,762,500) and 1.25% ($4,312,500), respectively, or 3.5% ($12,075,000), in the aggregate, of the gross proceeds of the Initial Public Offering including the gross proceeds from the full or partial exercise of the underwriters’ over-allotment option. A portion of such fee may be re-allocated or paid to members of Financial Industry Regulatory Authority (FINRA) that assist the Company in consummating its Business Combination. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. ​ No Working Capital Loans were outstanding as of December 31, 2021. On February 3, 2022, the Company entered into a Working Capital Loan with the Sponsor (the “Convertible Promissory Note”), pursuant to which the Company received proceeds of $750,000. On August 26, 2022, the Company drew down on the Convertible Promissory Note another $300,000. The Convertible Promissory Note is non-interest bearing and payable only upon the completion of a Business Combination. The Convertible Promissory Note may be convertible into warrants of the post-Business Combination entity at the option of the Sponsor at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. The aggregate fair value of the note was estimated by the Company to be $235,200 at initial measurement and $81,000 at September 30, 2022 (see Note 9).

WARRANTS

WARRANTS	9 Months Ended
	Sep. 30, 2022
WARRANTS.
WARRANTS	NOTE 7. WARRANTS Warrants The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A common stock issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Once the Public Warrants become exercisable, the Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the closing price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30- trading day period commencing after the warrants become exercisable and ending three business days before the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The exercise price and number of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the common shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. There were 8,625,000 Public Warrants and 5,933,333 Private Placement Warrants outstanding as of September 30, 2022 and December 31, 2021, respectively. The Company accounts for the Public Warrants and Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The accounting treatment of derivative financial instruments required that the Company record the warrants as derivative liabilities at fair value upon the closing of the Initial Public Offering. The Public Warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value. The warrant liabilities are subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liabilities are adjusted to current fair value, with the change in fair value recognized in the Company’s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

STOCKHOLDERS EQUITY (DEFICIT)

STOCKHOLDERS EQUITY (DEFICIT)	9 Months Ended
	Sep. 30, 2022
STOCKHOLDERS' EQUITY (DEFICIT)
STOCKHOLDERS' EQUITY (DEFICIT)	NOTE 8. STOCKHOLDERS’ EQUITY (DEFICIT) Preferred stock Class A common stock Class B common stock Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock upon the consummation of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion, including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in a Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2022
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 9. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis September 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amount at ​ ​ ​ ​ ​ ​ ​ ​ ​ Description Fair Value Level 1 Level 2 Level 3 September 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Assets ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account: ​ ​ ​ ​ ​ ​ Money Market investments ​ $ 347,314,019 ​ $ 347,314,019 ​ $ — ​ $ — Liabilities ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Warrant liability – Public Warrants ​ $ 345,000 ​ $ 345,000 ​ $ — ​ $ — Warrant liability – Private Placement Warrants ​ $ 237,333 ​ $ — ​ $ — ​ $ 237,333 Convertible promissory note - related party ​ $ 81,000 ​ $ — ​ $ — ​ $ 81,000 December 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Assets ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Money Market investments ​ $ 345,095,241 ​ $ 345,095,241 ​ $ — ​ $ — Liabilities ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Warrant liability – Public Warrants ​ $ 7,072,500 ​ $ 7,072,500 ​ $ — ​ $ — Warrant liability – Private Placement Warrants ​ $ 4,924,666 ​ $ — ​ $ — ​ $ 4,924,666 ​ The Company utilized a Monte Carlo simulation model for the initial valuation of the Public Warrants. The subsequent measurement of the Public Warrants as of September 30, 2022 and December 31, 2021 is classified as Level 1 due to the use of an observable market quote in an active market under the ticker ACII WS. The quoted price of the Public Warrants was $0.04 and $0.82 per warrant as of September 30, 2022 and December 31, 2021, respectively. The Company utilizes a Modified Black-Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the Private Placement Warrant liability is determined using Level 3 inputs. Inherent in a Modified Black-Scholes options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. The aforementioned warrant liabilities are not subject to qualified hedge accounting. Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants in the table above transferred from a Level 3 measurement to a Level 1 fair value measurement in March 2021 when the Public Warrants were separately listed and traded. The following table provides the significant inputs to the Monte Carlo Simulation for the initial fair value of the Public Warrants: ​ ​ ​ ​ ​ ​ ​ As of February 8, ​ ​ 2021 (Initial ​ ​ ​ Measurement) ​ Stock price $ 10.00 Strike price $ 11.50 Probability of completing a Business Combination ​ 86.0 % Expected life of the option to convert (in years) ​ 6.1 Volatility ​ 6.0% pre-merger / Risk-free rate ​ 0.7 % Fair value of warrants $ 1.52 ​ The following table provides the significant inputs to the Modified Black-Scholes model for the fair value of the Private Placement Warrants: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of February ​ ​ As of September 30, As of December 31, ​ 8, 2021 (Initial ​ 2022 2021 Measurement) ​ Stock price ​ $ 9.85 ​ $ 9.73 ​ $ 10.00 ​ Strike price ​ $ 11.50 ​ $ 11.50 ​ $ 11.50 ​ Probability of completing a Business Combination ​ 8.0 % ​ * ​ 86.0 % Dividend yield ​ ​ — % ​ — % ​ — % Remaining term (in years) ​ 5.4 ​ ​ 5.8 ​ 6.1 ​ Volatility 1.4 % ​ 12.8 % 22.0 % Risk-free rate ​ ​ 4.0 % ​ 1.3 % ​ 0.7 % Fair value of warrants ​ $ 0.04 ​ $ 0.83 ​ $ 1.52 ​ * The probability of completing a Business Combination is considered within the volatility implied by the traded price of the Public Warrants which is used to value the Private Placement Warrants. The convertible promissory note - related party was valued using a combination of Black-Scholes and Discounted Cash Flows methods, which is considered to be a Level 3 fair value measurement. The estimated fair value of the convertible promissory note - related party was based on the following significant inputs: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of August 26, As of February 4, ​ ​ As of September 30, ​ 2022 (Initial ​ 2022 (Initial ​ ​ 2022 ​ Measurement) ​ Measurement) Warrant price ​ $ 0.04 ​ $ 0.08 ​ $ 0.45 ​ Conversion price ​ $ 1.50 ​ $ 1.50 ​ $ 1.50 ​ Expected term ​ ​ 0.4 ​ ​ 0.5 ​ ​ 0.7 ​ Warrant volatility ​ ​ 191.0 % ​ 176.0 % ​ 86.3 % Risk free rate ​ ​ 3.6 % ​ 3.2 % ​ 0.7 % Discount rate ​ ​ 9.1 % ​ 6.6 % ​ 4.0 % Probability of completing a Business ​ ​ 8.0 % ​ 10.0 % ​ 28.0 % Fair value convertible promissory note - related party ​ $ 81,000 ​ $ 29,100 ​ $ 206,100 ​ ​ The following table presents the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value: ​ ​ ​ ​ ​ Fair value as of December 31, 2020 ​ $ — Initial measurement of Public Warrants and Private Placement Warrants at February 8, 2021 ​ 22,128,670 Transfer of Public Warrants to Level 1 measurement ​ ​ (7,331,250) Change in fair value ​ ​ (9,635,416) Fair value as of March 31, 2021 ​ ​ 5,162,004 Change in fair value ​ 1,839,333 Fair value as of June 30, 2021 ​ ​ 7,001,337 Change in fair value ​ ​ (1,958,004) Fair value as of September 30, 2021 ​ $ 5,043,333 ​ ​ ​ ​ ​ Fair value as of December 31, 2021 ​ $ 4,924,666 Initial measurement of convertible promissory note - related party on February 4, 2022 ​ 206,100 Change in fair value ​ ​ (3,021,766) Fair value as of March 31, 2022 ​ ​ 2,109,000 Change in fair value ​ ​ (1,185,433) Fair value as of June 30, 2022 ​ ​ 923,567 Initial measurement of convertible promissory note - related party draw on August 26, 2022 ​ ​ 29,100 Change in fair value ​ (634,334) Fair value as of September 30, 2022 ​ $ 318,333 ​ The Company recognized gains in connection with changes in the fair value of the Public Warrants and Private Placement Warrants of $1,455,834 and $11,414,833 within change in fair value of warrant liabilities in the condensed statements of operations for the three and nine months ended September 30, 2022, respectively. The gains on the change in fair value of warrant liabilities for the three and nine months ended September 30, 2022 was due in large part to the decrease in the public traded price of the Public Warrants. The Company recognized gains in connection with changes in the fair value of the Public Warrants and Private Placement Warrants of $4,545,504 and $9,754,087 in connection with changes in the fair value of the Public Warrants and Private Placement Warrants within change in fair value of warrant liabilities in the condensed statements of operations for the three and nine months ended September 30, 2021, respectively. The Company recognized gains on the change in fair value of convertible promissory note - related party of $41,000 and $154,200 in the condensed statement of operations for the three and nine months ended September 30, 2022, respectively. The Company did not recognize a gain or loss on the change in fair value of convertible promissory note - related party in the condensed statement of operations for the three and nine months ended September 30, 2021, respectively, as the convertible promissory note was not outstanding during the periods.

INCOME TAX

INCOME TAX	9 Months Ended
	Sep. 30, 2022
INCOME TAX
INCOME TAX	NOTE 10. INCOME TAX The Company’s effective tax rate for the three and nine months ended September 30, 2022 was 15.2% and 3.9%, respectively. The Company’s effective tax rate for the three and nine months ended September 30, 2021 was 0.0%. The Company’s effective tax rate differs from the statutory income tax rate of 21% primarily due to the recognition of gains or losses from the change in the fair value of warrant liabilities and convertible promissory note, nondeductible stock-based compensation, and nondeductible cash compensation, which are not recognized for tax purposes, and recording a full valuation allowance on deferred tax assets. The Company has historically calculated the provision for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss for the reporting period. The Company has used a discrete effective tax rate method to calculate taxes for the three and nine months ended September 30, 2022. The Company believes that, at this time, the use of the discrete method for the three and nine months ended September 30, 2022 is more appropriate than the estimated annual effective tax rate method as the estimated annual effective tax rate method is not reliable due to a high degree of uncertainty in estimating annual pretax earnings.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2022
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, other then described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements. On October 25, 2022, the Company filed a preliminary proxy statement to seek stockholder approval to adopt amendments to its Amended and Restated Certificate of Incorporation to allow the Company to redeem all of its outstanding public shares and liquidate no later than December 30, 2022, in advance of the automatic termination date in its current Certificate of Incorporation of February 8, 2023. On October 26, 2022, the NYSE notified the Company, and publicly announced, that the NYSE determined to commence proceedings to delist the Company’s warrants from the NYSE and that trading in the Company’s warrants would be suspended immediately. As a result of the expected expiration of the warrants with the expected liquidation of the Company, the Company does not intend to appeal the NYSE’s determination.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements of the Company are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 18, 2022. The interim results for the periods presented are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future interim periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. The Company has implemented the aforementioned exemptions. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2022 and December 31, 2021. As of September 30, 2022 and December 31, 2021, the Company had operating cash (i.e. cash held outside the Trust Account) of $308,920 and $125,304, respectively.
Investments Held in Trust Account	Investments Held in Trust Account At September 30, 2022 and December 31, 2021, the assets held in the Trust Account were held in money market funds, which are invested in U.S. Treasury securities. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in gain on investments held in Trust Account in the accompanying statements of operations. Interest income from investments held in Trust Account is included in gain on investments held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption All of the 34,500,000 shares of Class A common stock sold as part of the Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Amended and Restated Certificate of Incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Therefore, all Class A common stock has been classified outside of permanent equity. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid-in capital and accumulated deficit. The redemption value of the redeemable common stock as of September 30, 2022 increased as the income earned on the Trust Account exceeds the Company’s expected tax obligations plus up to $100,000 to pay dissolution expenses (see Note 1). As such, the Company recorded an increase in the carrying amount of the redeemable common stock of $1,776,862 during the nine months ended September 30, 2022. As of September 30, 2022 and December 31, 2021, the Class A common stock subject to redemption reflected in the balance sheet are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 345,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (13,110,000) Issuance costs allocated to Class A common stock ​ (7,053,627) Plus: ​ ​ Accretion of carrying value to redemption value ​ 20,163,627 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 345,000,000 Accretion of carrying value to redemption value ​ ​ 1,776,862 Class A common stock subject to possible redemption at September 30, 2022 ​ $ 346,776,862
Offering Costs associated with the Initial Public Offering	Offering Costs associated with the Initial Public Offering The Company complies with the requirements of ASC Topic 340, Other Assets and Deferred Costs Expenses of Offering
Warrant Liabilities	Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC Topic 815, Derivatives and Hedging For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The initial fair value of the Public Warrants was estimated using a Monte Carlo simulation approach and the initial and subsequent fair value of the Private Placement Warrants was estimated using a Modified Black-Scholes model. The subsequent measurement of the fair value of the Public Warrants was measured using quoted market prices (see Note 9).
Convertible Promissory Note - Related Party	Convertible Promissory Note - Related Party The Company accounts for the convertible promissory notes under ASC 815. The Company has made the election under 815-15-25 to account for the notes under the fair value option. Using the fair value option, the convertible promissory notes are required to be recorded at their initial fair value on the date of issuance, and each balance sheet thereafter. Differences between the face value of the note and fair value at issuance are recognized as either an expense in the statement of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as non-cash gains or losses in the statement of operations.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation - Stock Compensation
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. While ASC 740 identifies usage of an effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they are significant, unusual or infrequent. Computing the effective tax rate for the Company is complicated due to the potential impact of the Company’s change in fair value of warrants (or any other change in fair value of a complex financial instrument), the timing of any potential business combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expense in a current period based on ASC 740-270-25-3 which states, “If an entity is unable to estimate a part of its ordinary income (or loss) or the related tax (benefit) but is otherwise able to make a reasonable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate. As such, the Company is computing its taxable income and associated income tax provision based on actual results through September 30, 2022. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023 (the “Excise Tax”). The Excise Tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the Excise Tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the Excise Tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the Excise Tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the Excise Tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, votes relating to certain amendments to the Company’s Amended and Restated Certificate of Incorporation or otherwise, may be subject to the Excise Tax. Whether and to what extent the Company would be subject to the Excise Tax in connection with a Business Combination, votes relating to certain amendments to the Company’s Amended and Restated Certificate of Incorporation or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. The mechanics of any required payment of the Excise Tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to effect an extension of the time in which the Company must complete a Business Combination or complete a Business Combination. Further, the application of the Excise Tax in the event of a liquidation is uncertain. See Note 10 for additional information on income taxes for the periods presented.
Net Income Per Share of Common Stock	Net Income Per Share of Common Stock Net income per common share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period. Accretion associated with the redeemable shares of Class A common stock is excluded from net income per share as the redemption value approximates fair value. Therefore, the earnings per share calculation allocates income and losses shared pro rata between Class A and Class B common stock. As a result, the calculated net income per share is the same for Class A and Class B shares of common stock. The Company has not considered the effect of the Public Warrants and Private Placement Warrants to purchase an aggregate of 14,558,333 shares in the calculation of diluted net income per share, since the exercise of the warrants are contingent upon the occurrence of future events. The following table reflects the calculation of basic and diluted net income per common share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Three Months Ended ​ Nine Months Ended ​ Nine Months Ended ​ ​ September 30, 2022 ​ September 30, 2021 ​ September 30, 2022 ​ September 30, 2021 ​ Class A Class B Class A Class B Class A Class B Class A ​ Class B Basic and diluted net income per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 1,994,896 ​ $ 498,724 ​ $ 3,397,896 ​ $ 849,474 ​ $ 9,731,166 ​ $ 2,432,792 ​ $ 6,637,190 ​ $ 1,899,775 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 29,571,429 ​ ​ 8,464,286 Basic and diluted net income per share ​ $ 0.06 ​ $ 0.06 ​ $ 0.10 ​ $ 0.10 ​ $ 0.28 ​ $ 0.28 ​ $ 0.22 ​ $ 0.22
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company applies ASC Topic 820, Fair Value Measurement (“ASC 820”), which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. The carrying amounts reflected in the balance sheet for current assets and current liabilities (with the exception of the convertible promissory note - related party) approximate fair value due to their short-term nature. Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. See Note 9 for additional information on assets and liabilities measured at fair value.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Summary of reconciliation of Class A common stock subject to redemption reflected in the balance sheet	As of September 30, 2022 and December 31, 2021, the Class A common stock subject to redemption reflected in the balance sheet are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 345,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (13,110,000) Issuance costs allocated to Class A common stock ​ (7,053,627) Plus: ​ ​ Accretion of carrying value to redemption value ​ 20,163,627 Class A common stock subject to possible redemption at December 31, 2021 ​ ​ 345,000,000 Accretion of carrying value to redemption value ​ ​ 1,776,862 Class A common stock subject to possible redemption at September 30, 2022 ​ $ 346,776,862
Schedule of basic and diluted net income (loss) per common share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ Three Months Ended ​ Nine Months Ended ​ Nine Months Ended ​ ​ September 30, 2022 ​ September 30, 2021 ​ September 30, 2022 ​ September 30, 2021 ​ Class A Class B Class A Class B Class A Class B Class A ​ Class B Basic and diluted net income per share: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Net income ​ $ 1,994,896 ​ $ 498,724 ​ $ 3,397,896 ​ $ 849,474 ​ $ 9,731,166 ​ $ 2,432,792 ​ $ 6,637,190 ​ $ 1,899,775 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average shares outstanding ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 34,500,000 ​ ​ 8,625,000 ​ ​ 29,571,429 ​ ​ 8,464,286 Basic and diluted net income per share ​ $ 0.06 ​ $ 0.06 ​ $ 0.10 ​ $ 0.10 ​ $ 0.28 ​ $ 0.28 ​ $ 0.22 ​ $ 0.22

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2022
FAIR VALUE MEASUREMENTS
Schedule of financial assets and liabilities that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Amount at ​ ​ ​ ​ ​ ​ ​ ​ ​ Description Fair Value Level 1 Level 2 Level 3 September 30, 2022 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Assets ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account: ​ ​ ​ ​ ​ ​ Money Market investments ​ $ 347,314,019 ​ $ 347,314,019 ​ $ — ​ $ — Liabilities ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Warrant liability – Public Warrants ​ $ 345,000 ​ $ 345,000 ​ $ — ​ $ — Warrant liability – Private Placement Warrants ​ $ 237,333 ​ $ — ​ $ — ​ $ 237,333 Convertible promissory note - related party ​ $ 81,000 ​ $ — ​ $ — ​ $ 81,000 December 31, 2021 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Assets ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Investments held in Trust Account: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Money Market investments ​ $ 345,095,241 ​ $ 345,095,241 ​ $ — ​ $ — Liabilities ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Warrant liability – Public Warrants ​ $ 7,072,500 ​ $ 7,072,500 ​ $ — ​ $ — Warrant liability – Private Placement Warrants ​ $ 4,924,666 ​ $ — ​ $ — ​ $ 4,924,666
Schedule of significant inputs to the Monte Carlo Simulation and Modified Black Scholes model for the fair value	​ ​ ​ ​ ​ ​ ​ As of February 8, ​ ​ 2021 (Initial ​ ​ ​ Measurement) ​ Stock price $ 10.00 Strike price $ 11.50 Probability of completing a Business Combination ​ 86.0 % Expected life of the option to convert (in years) ​ 6.1 Volatility ​ 6.0% pre-merger / Risk-free rate ​ 0.7 % Fair value of warrants $ 1.52 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of February ​ ​ As of September 30, As of December 31, ​ 8, 2021 (Initial ​ 2022 2021 Measurement) ​ Stock price ​ $ 9.85 ​ $ 9.73 ​ $ 10.00 ​ Strike price ​ $ 11.50 ​ $ 11.50 ​ $ 11.50 ​ Probability of completing a Business Combination ​ 8.0 % ​ * ​ 86.0 % Dividend yield ​ ​ — % ​ — % ​ — % Remaining term (in years) ​ 5.4 ​ ​ 5.8 ​ 6.1 ​ Volatility 1.4 % ​ 12.8 % 22.0 % Risk-free rate ​ ​ 4.0 % ​ 1.3 % ​ 0.7 % Fair value of warrants ​ $ 0.04 ​ $ 0.83 ​ $ 1.52 ​ * The probability of completing a Business Combination is considered within the volatility implied by the traded price of the Public Warrants which is used to value the Private Placement Warrants. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ As of August 26, As of February 4, ​ ​ As of September 30, ​ 2022 (Initial ​ 2022 (Initial ​ ​ 2022 ​ Measurement) ​ Measurement) Warrant price ​ $ 0.04 ​ $ 0.08 ​ $ 0.45 ​ Conversion price ​ $ 1.50 ​ $ 1.50 ​ $ 1.50 ​ Expected term ​ ​ 0.4 ​ ​ 0.5 ​ ​ 0.7 ​ Warrant volatility ​ ​ 191.0 % ​ 176.0 % ​ 86.3 % Risk free rate ​ ​ 3.6 % ​ 3.2 % ​ 0.7 % Discount rate ​ ​ 9.1 % ​ 6.6 % ​ 4.0 % Probability of completing a Business ​ ​ 8.0 % ​ 10.0 % ​ 28.0 % Fair value convertible promissory note - related party ​ $ 81,000 ​ $ 29,100 ​ $ 206,100 ​
Schedule of changes in the fair value of the Level 3 financial instruments that are measured at fair value	​ ​ ​ ​ ​ Fair value as of December 31, 2020 ​ $ — Initial measurement of Public Warrants and Private Placement Warrants at February 8, 2021 ​ 22,128,670 Transfer of Public Warrants to Level 1 measurement ​ ​ (7,331,250) Change in fair value ​ ​ (9,635,416) Fair value as of March 31, 2021 ​ ​ 5,162,004 Change in fair value ​ 1,839,333 Fair value as of June 30, 2021 ​ ​ 7,001,337 Change in fair value ​ ​ (1,958,004) Fair value as of September 30, 2021 ​ $ 5,043,333 ​ ​ ​ ​ ​ Fair value as of December 31, 2021 ​ $ 4,924,666 Initial measurement of convertible promissory note - related party on February 4, 2022 ​ 206,100 Change in fair value ​ ​ (3,021,766) Fair value as of March 31, 2022 ​ ​ 2,109,000 Change in fair value ​ ​ (1,185,433) Fair value as of June 30, 2022 ​ ​ 923,567 Initial measurement of convertible promissory note - related party draw on August 26, 2022 ​ ​ 29,100 Change in fair value ​ (634,334) Fair value as of September 30, 2022 ​ $ 318,333

DESCRIPTION OF ORGANIZATION, _2

DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN (Details)		9 Months Ended
	Feb. 08, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) $ / shares
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN
Condition for future business combination number of businesses minimum		1
Shares issued price per share | $ / shares		$ 10
Redemption of shares calculated based on business days prior to consummation of business combination (in days)		185 days
Percentage of fair market value		80%
Outstanding voting securities		50%
Net tangible assets		$ 5,000,001
Maximum period to complete business combination from closing date of ipo		24 months
Redeem public shares, percentage		100%
Threshold business days for redemption of public shares		10 days
Interest to pay dissolution expenses		$ 100,000
Initial Public Offering
DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS AND GOING CONCERN
Number of units issued | shares	34,500,000
Shares issued price per share | $ / shares	$ 10	$ 10
Proceeds from issuance initial public offering	$ 345,000,000
Amount of net proceed from sale of units	345,000,000
Transaction costs	7,343,549
Underwriting fees	6,900,000
Other offering costs	$ 443,549

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)			3 Months Ended	9 Months Ended		12 Months Ended
	Aug. 16, 2022	Feb. 08, 2021	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash equivalents			$ 0	$ 0		$ 0
Operating cash			308,920	308,920		125,304
Dissolution expenses				100,000
Accretion of carrying value to redemption value			1,776,862	1,776,862		20,163,627
Expensed offering costs		$ 289,922			$ 289,922
Unrecognized tax benefits			0	0		0
Unrecognized tax benefits accrued for interest and penalties			$ 0	$ 0		$ 0
Purchase of aggregate shares				14,558,333
Percentage of excise tax on fair market value	1%
Federal
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Percentage of excise tax on fair market value	1%
Class A Common Stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Other offering costs		$ 7,053,627
Initial Public Offering
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Sale of units, net of underwriting discounts (in shares)		34,500,000
Transaction costs		$ 7,343,549
Underwriting fees		6,900,000
Other offering costs		$ 443,549
Initial Public Offering | Class A Common Stock
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Sale of units, net of underwriting discounts (in shares)				34,500,000

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Common Stock Subject to Possible Redemption (Details) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Gross proceeds			$ 345,000,000
Proceeds allocated to Public Warrants			(13,110,000)
Issuance costs allocated to Class A common stock			(7,053,627)
Accretion of carrying value to redemption value	$ 1,776,862	$ 1,776,862	20,163,627
Class A common stock subject to possible redemption	$ 346,776,862	$ 346,776,862	$ 345,000,000

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income (Loss) Per Share of Common Stock (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Class A Common Stock
Numerator:
Net income	$ 1,994,896	$ 3,397,896	$ 9,731,166	$ 6,637,190
Denominator:
Basic weighted average shares outstanding	34,500,000	34,500,000	34,500,000	29,571,429
Diluted weighted average shares outstanding	34,500,000	34,500,000	34,500,000	29,571,429
Basic net income per share	$ 0.06	$ 0.10	$ 0.28	$ 0.22
Diluted net income per share	$ 0.06	$ 0.10	$ 0.28	$ 0.22
Class B Common Stock
Numerator:
Net income	$ 498,724	$ 849,474	$ 2,432,792	$ 1,899,775
Denominator:
Basic weighted average shares outstanding	8,625,000	8,625,000	8,625,000	8,464,286
Diluted weighted average shares outstanding	8,625,000	8,625,000	8,625,000	8,464,286
Basic net income per share	$ 0.06	$ 0.10	$ 0.28	$ 0.22
Diluted net income per share	$ 0.06	$ 0.10	$ 0.28	$ 0.22

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)		9 Months Ended
	Feb. 08, 2021	Sep. 30, 2022	Dec. 31, 2021
INITIAL PUBLIC OFFERING
Shares issued price per share		$ 10
Initial Public Offering
INITIAL PUBLIC OFFERING
Number of units issued	34,500,000
Shares issued price per share	$ 10	10
Proceeds from issuance initial public offering	$ 345,000,000
Number of warrants in a unit	0.25
Class A Common Stock
INITIAL PUBLIC OFFERING
Common shares, par value (per share)		$ 0.0001	$ 0.0001
Class A Common Stock | Initial Public Offering
INITIAL PUBLIC OFFERING
Number of units issued		34,500,000
Number of shares in a unit	1
Common shares, par value (per share)	$ 0.0001
Class A Common Stock | Initial Public Offering | Public Warrants
INITIAL PUBLIC OFFERING
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)		9 Months Ended
	Feb. 08, 2021	Sep. 30, 2022	Sep. 30, 2021
Private Placement [Line Items]
Proceeds from sale of private placement warrants	$ 8,900,000		$ 8,900,000
Share price		$ 9.20
Loss on sale of private placement warrants			$ (118,670)
Private Placement | Private Placement Warrants
Private Placement [Line Items]
Number of warrants sold	5,933,333
Warrants per share price	$ 1.50
Class A Common Stock | Private Placement Warrants
Private Placement [Line Items]
Number of common stock purchased by exercisable of each warrants		1
Share price		$ 11.50

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)		1 Months Ended
	Dec. 23, 2020 USD ($) D $ / shares shares	Feb. 28, 2021 shares	Sep. 30, 2022 shares	Dec. 31, 2021 shares
Class B Common Stock
RELATED PARTY TRANSACTIONS
Common shares, issued			8,625,000	8,625,000
Common shares, outstanding			8,625,000	8,625,000
Restrictions on transfer period of time after business combination completion	1 year
Class B Common Stock | Over-allotment option
RELATED PARTY TRANSACTIONS
Shares subject to forfeiture		1,125,000
Sponsor
RELATED PARTY TRANSACTIONS
Percentage of issued and outstanding shares after the initial public offering collectively held by initial stockholders		20%
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares	$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D	20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | D	30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences	150 days
Sponsor | Class B Common Stock
RELATED PARTY TRANSACTIONS
Shares issued	7,187,500
Issuance of Class B common stock to Sponsor | $	$ 25,000
Stock dividend per share		0.2
Common shares, issued		8,625,000
Common shares, outstanding		8,625,000

RELATED PARTY TRANSACTIONS - St

RELATED PARTY TRANSACTIONS - Stock-Based Compensation (Details)							3 Months Ended	9 Months Ended
	Jun. 22, 2022 USD ($) $ / shares shares	Jun. 03, 2022 USD ($) $ / shares shares	Dec. 27, 2021 USD ($) shares	Dec. 21, 2021 USD ($) director $ / shares	Oct. 04, 2021 USD ($) item $ / shares shares	Jan. 15, 2021 USD ($) director $ / shares shares	Sep. 30, 2022 USD ($) $ / shares	Sep. 30, 2022 USD ($) $ / shares
RELATED PARTY TRANSACTIONS
Number of directors | director						2
Number of executives | item					1
Stock-based compensation expense							$ 46,712	$ 92,275
Share price | $ / shares							$ 10	$ 10
Accrued compensation							$ 92,275	$ 92,275
Founder Shares
RELATED PARTY TRANSACTIONS
Number of shares transferred | shares	25,000
Original Grant
RELATED PARTY TRANSACTIONS
Stock-based compensation expense						$ 0
Grant to Executive
RELATED PARTY TRANSACTIONS
Stock-based compensation expense					$ 0
Second Directors
RELATED PARTY TRANSACTIONS
Number of directors resigned | director				1
Cash consideration				$ 0
Stock-based compensation expense	$ 29,250			$ 0
Share price | $ / shares	$ 1.17
Third Directors
RELATED PARTY TRANSACTIONS
Stock-based compensation expense			$ 0				4,990	15,024
Share price | $ / shares		$ 1.18
Exercise price of warrant | $ / shares		$ 0.21
Aggregate warrant price		$ 21,857
Third Directors | Private Placement Warrants
RELATED PARTY TRANSACTIONS
Warrants outstanding | shares		81,250
Third Directors | Founder Shares
RELATED PARTY TRANSACTIONS
Number of shares transferred | shares		20,937
Retained shares | shares		4,063
Fourth Directors
RELATED PARTY TRANSACTIONS
Stock-based compensation expense							$ 7,576	9,799
Share price | $ / shares		$ 1.18
Exercise price of warrant | $ / shares		$ 0.21
Aggregate warrant price		$ 20,175
Fourth Directors | Private Placement Warrants
RELATED PARTY TRANSACTIONS
Number of shares transferred | shares		75,000
Fourth Directors | Founder Shares
RELATED PARTY TRANSACTIONS
Number of shares transferred | shares		3,750
Sponsor
RELATED PARTY TRANSACTIONS
Fair value of Interest per share | $ / shares				$ 3.93
Aggregate fair value of interest amount				$ 98,250
Sponsor | Original Grant
RELATED PARTY TRANSACTIONS
Fair value of grant | $ / shares						$ 6.15
Aggregate fair value of grant amount						$ 307,500
Sponsor | Director | Original Grant
RELATED PARTY TRANSACTIONS
Number of shares transferred | shares						25,000
Aggregate number of shares transferred to directors | shares						50,000
Cash consideration						$ 0
Sponsor | Third Directors
RELATED PARTY TRANSACTIONS
Number of shares transferred | shares			25,000
Cash consideration								81,250
Sponsor | Fourth Directors
RELATED PARTY TRANSACTIONS
Cash consideration								$ 75,000
Sponsor | Executive | Grant to Executive
RELATED PARTY TRANSACTIONS
Fair value of Interest per share | $ / shares					$ 4.34
Aggregate fair value of interest amount					$ 603,167
Sponsor | Executive | Grant to Executive | Warrants
RELATED PARTY TRANSACTIONS
Fair value of Interest per share | $ / shares					$ 0.91
Sponsor | Executive | Grant to Executive | Private Placement Warrants
RELATED PARTY TRANSACTIONS
Number of shares transferred | shares					66,667
Sponsor | Executive | Grant to Executive | Founder Shares
RELATED PARTY TRANSACTIONS
Number of shares transferred | shares					125,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 29, 2020
Sponsor
RELATED PARTY TRANSACTIONS
Sponsor repaid					$ 20,000
Promissory Note with Related Party
RELATED PARTY TRANSACTIONS
Maximum borrowing capacity of related party promissory note						$ 300,000
Outstanding balance of related party note						$ 300,000
Administrative Support Agreement
RELATED PARTY TRANSACTIONS
Expenses per month			$ 10,000
Expenses incurred and paid	$ 30,000	$ 30,000	$ 60,000	$ 80,000

COMMITMENTS (Details)

COMMITMENTS (Details)			9 Months Ended
	Aug. 26, 2022 USD ($)	Feb. 03, 2022 USD ($) $ / shares	Sep. 30, 2022 USD ($) item $ / shares	Dec. 31, 2021 USD ($)
COMMITMENTS
Maximum number of demands for registration of securities | item			3
Working capital loans			$ 1,500,000
Sponsor
COMMITMENTS
Warrants per share price | $ / shares		$ 1.50	$ 1.50
Working capital loans outstanding				$ 0
Proceeds from working capital loan		$ 750,000
Convertible promissory note	$ 300,000
Estimated fair value of convertible promissory note at initial measurement			$ 235,200
Estimated fair value of convertible promissory note			$ 81,000
Business Combination Marketing Agreement
COMMITMENTS
Aggregate cash fee payable upon consummation of business combination, percent			3.50%
Aggregate cash fee payable upon consummation of business combination, amount			$ 12,075,000
Business Combination Marketing Agreement | Underwriters
COMMITMENTS
Aggregate cash fee payable upon consummation of business combination, percent			2.25%
Aggregate cash fee payable upon consummation of business combination, amount			$ 7,762,500
Business Combination Marketing Agreement | Moelis & Company LLC
COMMITMENTS
Aggregate cash fee payable upon consummation of business combination, percent			1.25%
Aggregate cash fee payable upon consummation of business combination, amount			$ 4,312,500

WARRANTS (Details)

WARRANTS (Details)	9 Months Ended
	Sep. 30, 2022 D $ / shares shares	Dec. 31, 2021 shares
Warrants [Line Items]
Warrants exercisable term after the completion of a business combination	30 days
Public warrants expiration term	5 years
Threshold period for filling registration statement after business combination	15 days
Period of time within which registration statement is expected to become effective	60 days
Share price	$ 9.20
Threshold trading days determining volume weighted average price	20 days
Adjustment of exercise price of warrants based on market value (as a percent)	115%
Adjustment of redemption price of stock based on market value and newly issued price 2 (as a percent)	180%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Minimum [Member]
Warrants [Line Items]
Percentage of gross proceeds on total equity proceeds	60%
Initial Public Offering
Warrants [Line Items]
Warrants and rights outstanding exercisable term from closing of public offering	12 months
Warrant redemption condition minimum share price	$ 18
Public Warrants
Warrants [Line Items]
Warrants outstanding | shares	8,625,000	8,625,000
Private Placement
Warrants [Line Items]
Warrants outstanding | shares	5,933,333	5,933,333
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 | Public Warrants
Warrants [Line Items]
Redemption price per public warrant (in dollars per share)	$ 0.01
Redemption period	30 days
Warrant redemption condition minimum share price	$ 18
Threshold trading days for redemption of public warrants | D	20
Threshold consecutive trading days for redemption of public warrants | D	30
Threshold number of business days before sending notice of redemption to warrant holders | D	3

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT) - Preferred Stock (Details) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

STOCKHOLDERS' EQUITY (DEFICIT_2

STOCKHOLDERS' EQUITY (DEFICIT) - Common Stock (Details)	9 Months Ended
	Sep. 30, 2022 Vote $ / shares shares	Dec. 31, 2021 Vote $ / shares shares
Class A Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	200,000,000	200,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote	1	1
Common shares, shares issued (in shares)	34,500,000	34,500,000
Common shares, shares outstanding (in shares)	34,500,000	34,500,000
Issued and outstanding shares of public offering after transaction, percentage	20%
Class A Common Stock subject to possible redemption
Class of Stock [Line Items]
Class A common stock subject to possible redemption, outstanding (in shares)	34,500,000	34,500,000
Class B Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	20,000,000	20,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote	1
Common shares, shares issued (in shares)	8,625,000	8,625,000
Common shares, shares outstanding (in shares)	8,625,000	8,625,000
Ratio to be applied to the stock in the conversion	1

FAIR VALUE MEASUREMENTS - Fair

FAIR VALUE MEASUREMENTS - Fair value assets and liabilities measured on recurring basis (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Assets
Money Market investments	$ 347,314,019	$ 345,095,241
Liabilities
Convertible promissory note - related party	81,000
Public Warrants
Liabilities
Warrant liability	345,000	7,072,500
Private Placement Warrants
Liabilities
Warrant liability	237,333	4,924,666
Level 1
Assets
Money Market investments	347,314,019	345,095,241
Level 1 | Public Warrants
Liabilities
Warrant liability	$ 345,000	$ 7,072,500
Exercise price of warrant	$ 0.04	$ 0.82
Level 3
Liabilities
Convertible promissory note - related party	$ 81,000
Level 3 | Private Placement Warrants
Liabilities
Warrant liability	$ 237,333	$ 4,924,666

FAIR VALUE MEASUREMENTS - Signi

FAIR VALUE MEASUREMENTS - Significant inputs related to warrants (Details)	Sep. 30, 2022 $ / shares Y	Dec. 31, 2021 $ / shares Y	Feb. 08, 2021 $ / shares Y
Stock price | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			10
Stock price | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	9.85	9.73	10
Strike price | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			11.50
Strike price | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	11.50	11.50	11.50
Probability of completing a Business Combination | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			0.860
Probability of completing a Business Combination | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.080		0.860
Expected life of the option to convert (in years) | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input | Y			6.1
Remaining term (in years) | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input | Y	5.4	5.8	6.1
Volatility | Public Warrants | Pre-merger
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			0.060
Volatility | Public Warrants | Post-merger
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			0.250
Volatility | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.014	0.128	0.220
Risk-free rate | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			0.007
Risk-free rate | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.040	0.013	0.007
Fair value of warrants | Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			1.52
Fair value of warrants | Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.04	0.83	1.52

FAIR VALUE MEASUREMENTS - Sig_2

FAIR VALUE MEASUREMENTS - Significant inputs related to Convertible Promissory Note - Related Party (Details) - Convertible Promissory Note - Related Party	Sep. 30, 2022	Aug. 26, 2022	Feb. 04, 2022
Warrant price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.04	0.08	0.45
Conversion price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	1.50	1.50	1.50
Expected life of the option to convert (in years)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.4	0.5	0.7
Warrant volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	1.910	1.760	0.863
Risk-free rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.036	0.032	0.007
Discount rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.091	0.066	0.040
Probability of completing a Business
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.080	0.100	0.280
Fair value convertible promissory note - related party
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	81,000	29,100	206,100

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Level 3 Financial Instruments (Details) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
FAIR VALUE MEASUREMENTS
Fair value, Beginning Balance	$ 923,567	$ 2,109,000	$ 4,924,666	$ 7,001,337	$ 5,162,004		$ 4,924,666
Initial measurement of Public Warrants and Private Placement Warrants at February 8, 2021						$ 22,128,670
Initial measurement of convertible promissory note - related party	29,100		206,100
Transfer of Public Warrants to Level 1 measurement						(7,331,250)
Change in fair value	(634,334)	(1,185,433)	(3,021,766)	(1,958,004)	1,839,333	(9,635,416)
Fair value, Ending Balance	318,333	$ 923,567	$ 2,109,000	5,043,333	$ 7,001,337	$ 5,162,004	318,333	$ 5,043,333
Gain on change in fair value of warrant liabilities	1,455,834			4,545,504			11,414,833	9,754,087
Gain on change in fair value convertible promissory note - related party	$ 41,000			$ 0			$ 154,200	$ 0

INCOME TAX (Details)

INCOME TAX (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
INCOME TAX
Effective income tax rate	15.20%	0%	3.90%	0%
Statutory income tax rate			21%